{"brief_title": "Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients", "brief_summary": "Patients with congestive heart failure will be assessed for safety and clinical effects of Tolvaptan 30 mg every day versus 15 mg twice a day over a period of 7 days.", "condition": "Congestive Heart Failure", "intervention_type": "Drug", "intervention_name": "Tolvaptan", "criteria": "History of CHF", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00043771.xml"}